Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

Pfizer’s buyout bid for Metsera was deemed inferior to the latest bid from Novo Nordisk, putting the original agreement in ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

Blackstone Life Sciences agreed to give Merck $700 million to support its development of an investigational cancer drug called sacituzumab tirumotecan in exchange for low-to-mid-single-digit royalties ...

The number of medications in development to treat obesity continues to grow, and the drugs can offer health benefits for ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

NetTargets employs an AI system that combines multi-omics data with neural network modelling for drug discovery.

More than two weeks after President Donald Trump said he would halt “all payments” to Colombia, there has not been any ...

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, ...